Go to Bing homepage

Omnicare Inc. (OCR) was a big mover last session, as the company saw its shares rise over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend …

with trial failure likely due to dose level End of phase 2 meeting with FDA in 3Q17 will be a pivotal near-term catalyst Ocera Therapeutics (OCRX) is a clinical stage biopharmaceutical company, focused primarily on developing OCR-002 …

NICE (Nasdaq:NICE) today announced a new enhancement in its Robotic Process Automation (RPA) platform with the incorporation of the most advanced Optical Character Recognition (OCR) solution on the market. In an agreement with …

And holy cow, Wall Street is loving this deal. A beat on the company’s revenue, decent growth and this huge proposed deal are sending the stock skyrocketing, with shares up nearly 20 percent now that the news is out. To put that in …

* Mallinckrodt Plc - ‍Mallinckrodt to commence cash tender offer to purchase ocera therapeutics for $1.52 per share, plus contingent value right * Mallinckrodt Plc - ‍Assuming expected 2017 deal close, expects dilution from deal to adjusted …

OCR, an arm of the U.S. Department of Education, opened the inquiry into disability discrimination on Jan. 25, according to a department spokesman. The agency declined to release other details while the case is active. In an email, …

Investors in Omnicare Inc. (Symbol: OCR) saw new options become available today, for the May 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the OCR options chain for the new May 15th …

The following chart shows OCR's stock price since April 20, 2015. This chart shows OCR's trading prices from 4/20/15 to 6/5/15. Research OCR's press release explained that the acquisition by CVS Health will be completed via a merger, …